Catalyst Grant: HIV/AIDS Vaccine Discovery Research - Funding Decisions Notification (November 2008 Competition - 200811CHV)
(Alternate Title: Catalyst Grant: HIV/AIDS Vaccine Discovery Research (Can HIV Vaccine Initiative))The Canadian Institutes of Health Research (CIHR) is pleased to announce the results of the Catalyst Grant: HIV/AIDS Vaccine Discovery Research (Canadian HIV Vaccine Initiative) competition as part of the Canadian HIV Vaccine Initiative (CHVI).
Funding Opportunity Summary
CIHR invited applications from individuals or small teams of Canadian researchers interested in contributing toward the development of an HIV vaccine. The purpose of this funding opportunity is to further strengthen Canadian HIV/AIDS research by providing seed money, on a short-term basis, to support innovative health research activities which represent a first step towards the pursuit of more comprehensive funding opportunities (e.g. operating grants, team grants), such as pilot projects; and feasibility studies aimed at generating preliminary data, observations, or knowledge.
Within the framework of the overall objectives of the CIHR Catalyst Grant Program, the specific objectives of the Catalyst Grant: HIV/AIDS Vaccine Discovery Research are to:
- enable Canadian basic science and clinical researchers to explore unique/novel ideas and contribute to international efforts in HIV vaccine development;
- build capacity for HIV vaccines discovery research in Canada; and
- create mechanisms for individual investigators and teams funded under the initiative to network and share information with one another and other relevant international networks and consortia (e.g. other Gates Foundation funded programs, NIH and The Global HIV Vaccine Enterprise).
Funding Competition Summary
A total of seven applications were received of which five were approved for funding.
Contact Information
For further information about this competition, please contact:
Liliane Chénard
Team Lead, Program Delivery
Canadian Institutes of Health Research
Telephone: 613-957-3118
Fax: 613-954-1800
Email: liliane.chenard@cihr-irsc.gc.ca
For further information about this initiative and the objectives of this funding opportunity please contact:
Nancy Mason MacLellan
HIV/AIDS Research Initiative
Canadian Institutes of Health Research
160 Elgin St., Address locator: 4809A
Ottawa, ON K1A 5A3
Telephone: 613-952-3654
Fax: 613-954-1800
Email: nancy.masonmaclellan@cihr-irsc.gc.ca
Funding Decisions Data Report
Access the "Catalyst Grant: HIV/AIDS Vaccine Discovery Research (Can HIV Vaccine Initiative)" funding decisions data report.